| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5d1596f64ec0b2dac5334b2cf05b88bb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28 |
| filingDate |
2003-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c6aae6dc1658fb696c68cf5d750ddca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f60616c0cc8e19778f0a5fe22c3cab9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_029a28a2da38c33790ba88c505988314
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bcab26da6b5c712594a99a0f018b4c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55e2b8a6765a0ff5628257441550e373
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_739ee911d3a52563ec62d87144b8bbf1 |
| publicationDate |
2016-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
PL-223341-B1 |
| titleOfInvention |
A method for producing coated tablets containing vardenafil hydrochloride and coated tablets produced by this method |
| abstract |
Production of solid medicaments (A) containing vardenafil hydrochoride (I) in the form of the trihydrate involves using (I) of any water content in the production of (A) and converting (I) into the trihydrate form at an intermediate processing stage or in the final product. An independent claim is included for the medicaments (A) (specifically in coated tablet form) obtained by the process. ACTIVITY : Vasotropic. MECHANISM OF ACTION : None given in the source material. |
| priorityDate |
2002-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |